Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

BOM/531099 stock hub

BOM/531099 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/531099is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

239M

Bombay Stock Exchange

Market data

Price

Recent price action with selectable time range.

BOM/531099BOM/531099

—

Loading chart…

In the news

Latest news · BOM/531099

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E11.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC113.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/531099 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

153

Groups with data

Currency

INR

Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	4
Employees Change	-1%
Employees Change Percent	-20
Enterprise value	INR 237.7M
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	INR 239M
Price	INR 43.71
Price currency	INR
Rev Per Employee	736,610,750x
Sic	5122
Symbol	bom/531099
Website	https://www.rubramed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.57%
EV Earnings	11.6x
EV/EBIT	8.56x
EV/EBITDA	8.53x
EV/Sales	0.08x
P/B ratio	12.14x
P/E ratio	11.68x
P/S ratio	0.08x
PE Ratio10 Y	118.79x
PE Ratio3 Y	94.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.94%
EBITDA Margin	0.95%
Gross margin	1.55%
Gross Profit	INR 45.7M
Gross Profit Growth	533.34%
Gross Profit Growth Q	1,285.08%
Gross Profit Growth3 Y	38.95%
Gross Profit Growth5 Y	41.05%
Net Income	INR 20.5M
Net Income Growth3 Y	513.24%
Pretax Margin	0.92%
Profit Margin	0.7%
Profit Per Employee	INR 5.1M
Roa5y	-0.42
Roe5y	-1.84
ROIC	113.9
Roic5y	-1.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	70.67%
Cagr3y	103.42%
Cagr5y	81.34%
EPS Growth3 Y	547.2
Revenue Growth	40,752.75x
Revenue Growth Q	171,923.12x
Revenue Growth3 Y	457.26x
Revenue Growth5 Y	224.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.3M
Equity	INR 19.7M
Net Cash	INR 1.3M
Net Cash By Market Cap	INR 0.56
Net Cash Growth	267.12%
Net Debt EBITDA	INR -0.05
Net Debt Equity	INR -0.07
Tangible Book Value	INR 19.7M
Tangible Book Value Per Share	INR 3.61
WACC	6.39

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	70.61%
200-day SMA	69.98
3Y total return	742.2%
50-day SMA	52.61
50-day SMA vs 200-day SMA	50under200
5Y total return	1,860.09%
All Time High	144.4
All Time High Change	-69.73%
All Time High Date	2026-01-07
All Time Low	1.18
All Time Low Change	3,604.24%
All Time Low Date	2020-06-08
ATR	3.43
Beta	0.39
Beta1y	1.31
Beta2y	0.63
Ch YTD	-61.75
High	43.79
High52	144.4
High52 Date	2026-01-07
High52ch	-69.73%
Low	41.98
Low52	16.06
Low52 Date	2025-06-05
Low52ch	172.17%
Ma50ch	-16.91%
Price vs 200-day SMA	-37.54%
RSI	40.12
RSI Monthly	50.56
RSI Weekly	38.25
Sharpe ratio	1.09x
Sortino ratio	1.71
Tr YTD	-61.75
Tr1m	11.28%
Tr1w	1.35%
Tr3m	-58.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 27.8M
Operating Income Growth3 Y	401.4
Operating margin	0.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,635,261%
Shares Insiders	54.56%
Shares Institutions	5.89%
Shares Out	5,468,300
Shares Qo Q	0.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	25,993.1x
Bv Per Share	3.61
Ch1m	11.28
Ch1w	1.35
Ch1y	70.61
Ch3m	-58.63
Ch3y	742.2
Ch5y	1,860.1
Ch6m	-40.8
Change	4.8%
Change From Open	-0.09
Close	41.71
Days Gap	4.89
Depreciation Amortization	84,000
Dollar Volume	687,645.7
Earnings Date	2026-05-29
EBIT	INR 27.8M
EBITDA	INR 27.9M
EPS	INR 3.74
F Score	1
Fiscal Year End	March
Founded	1,991
Graham Number	17.41944
Graham Upside	-60.15
Income Tax	INR 6.8M
Is Primary Listing	1
Last Earnings Date	2026-01-28
Last Report Date	2025-12-31
Lynch Fair Value	INR 93.52
Lynch Upside	114
Ma150	80.19
Ma150ch	-45.49%
Ma20	50.56
Ma20ch	-13.54%
Next Earnings Date	2026-05-29
Open	43.75
Position In Range	95.58
Price Date	2026-05-08
Price EBITDA	INR 8.58
Ptbv Ratio	12.14
Relative Volume	0.61x
Revenue	2,946,443,000x
Tax By Revenue	0.23x
Tax Rate	24.8%
Tr6m	-40.8%
Volume	15,732

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/531099 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/531099 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/531099?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.9%

Share of float held by funds and institutions

Insider ownership

+54.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BOM/531099 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.1

Neutral momentum band

Price vs 200-day MA

-37.5%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

1.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/531099

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/531099 stock rating?

bom/531099 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/531099 analysis?

The full report lives at /stocks/bom/531099/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/531099?

The latest report frames bom/531099 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/531099 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.